Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma
British Journal of Haematology · 2026-11 · 209 (5) · 2284-2288
DOI: 10.1111/bjh.70803 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Haematology, online erschienen am 31.08.2026. Verfasst von Farrukh T Awan und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Texas Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Hematopoietic Stem Cell Transplantation, Pyrimidines, Pyrazoles. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- AbbVie, North Chicago, Illinois, USA.
- Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
ORCID-Profile: Farrukh T Awan, Hsin-Hui Huang, Kwang Woo Ahn, Heather Wolfe, Mehdi Hamadani
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
- AbbVie
Zitieren
APA
Awan, F. T., Liu, R., Huang, H. H., Bye, M., Ahn, K. W., Krigsfeld, G., Raz, A., Wolfe, H., & Hamadani, M. (2026). Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology, 209(5), 2284-2288. https://doi.org/10.1111/bjh.70803
Vancouver
Awan FT, Liu R, Huang HH, Bye M, Ahn KW, Krigsfeld G, et al. Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma. British Journal of Haematology. 2026;209(5):2284-2288. doi:10.1111/bjh.70803
BibTeX
@article{Awan2026,
author = {Awan, Farrukh T and Liu, Ran and Huang, Hsin-Hui and Bye, Matthew and Ahn, Kwang Woo and Krigsfeld, Gabriel and Raz, Anat and Wolfe, Heather and Hamadani, Mehdi},
title = {Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {5},
pages = {2284--2288},
doi = {10.1111/bjh.70803}
}
EUVIMED